Pulmonary inflammation due to exercise-induced pulmonary haemorrhage in Thoroughbred colts during race training

Vet J. 2011 Nov;190(2):e3-e6. doi: 10.1016/j.tvjl.2010.08.009.

Abstract

This study investigated the putative roles of inflammation and platelet-activating factor (PAF) in exercise-induced pulmonary haemorrhage (EIPH). Two-year-old Thoroughbred colts (n=37) were exercised on a racetrack for 5months before commencement of the study. Each colt was then exercised at 15-16m/s over 800-1000m and broncho-alveolar lavage fluid (BALF) was collected 24h later. The colts were subsequently divided into two groups on the basis of BALF analysis; an EIPH-positive group (presence of haemosiderophages, n=23) and an EIPH-negative group (absence of haemosiderophages, n=14). BALF from the EIPH-positive group had a significantly higher protein concentration (0.39±0.28 vs. 0.19±0.12mg/mL, P=0.031), higher PAF bioactivity (0.18±0.12 vs. 0.043±0.05 340:380nm ratio, P=0.042) and a higher lipid hydroperoxide concentration compared to the EIPH-negative group. There was also a lower nitrite concentration and reduced production of superoxide anion and hydrogen peroxide by alveolar macrophages in the EIPH-positive group. There was evidence of pulmonary inflammation and a decreased innate immune response of alveolar macrophages in EIPH-positive colts compared with the EIPH-negative group.

MeSH terms

  • Animals
  • Bronchoalveolar Lavage Fluid / chemistry
  • Bronchoalveolar Lavage Fluid / cytology*
  • Hemorrhage / etiology
  • Hemorrhage / metabolism
  • Hemorrhage / veterinary*
  • Horse Diseases / etiology*
  • Horse Diseases / metabolism
  • Horses
  • Inflammation / etiology
  • Inflammation / metabolism
  • Lung Diseases / etiology
  • Lung Diseases / metabolism
  • Lung Diseases / veterinary*
  • Macrophages, Alveolar / metabolism
  • Male
  • Oxidative Stress
  • Physical Conditioning, Animal / adverse effects*
  • Physical Conditioning, Animal / physiology
  • Platelet Activating Factor / metabolism

Substances

  • Platelet Activating Factor